ATYR

aTyr Pharma
ATYR

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$1
28% upside
High target

2 analyst ratings

positive
2  neutral
100%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
RBC Capital
RBC Capital
Brian Abrahams
7 Nov ‘25 23 days ago
Wells Fargo
Wells Fargo
Derek Archila
0% 1-yr ATYR win rate
16 Sep ‘25 2 months ago
HC Wainwright & Co
HC Wainwright & Co
Joseph Pantginis
60% 1-yr ATYR win rate
15 Sep ‘25 2 months ago